Posted on October 1st, 2021. Posted by ICR Westwicke
Investor meetings are essential for managing and expanding your shareholder base. They provide investors with clarity on a company’s story and can allow you to gauge potential investor concerns, but most importantly, they provide management the opportunity to control the story being told to investors.
The buy side often views a meeting with management as a critical component in their due diligence process. Even in the wake of increased scrutiny from SEC regulators regarding Reg FD, these meetings give the buy side more insight into a company story, recent developments, and potential headwinds.
Continue Reading
Posted on September 23rd, 2021. Posted by ICR Westwicke
The biotech market has been growing rapidly over the past two decades, and is expected to be worth nearly $2.5 trillion by 2028. Meanwhile, the pace of technological developments and innovation have reduced barriers to entry, leading to an influx of aspiring biotech startups eager to bring their products to market. But despite the increase in available capital, early-stage biotech companies are battling harder for their share of funding. In this article, we explore the challenges, strategies, and best practices in early-stage biotech funding.
Continue Reading
Posted on September 7th, 2021. Posted by ICR Westwicke
Why would anyone invest in a biotech or biopharma company? After all, most are development-stage companies based on complicated science that consume cash voraciously, have no revenue or earnings, and need to sell a dream that could be years away from commercialization.
The risks are enormous. Yet they attract investors because the payoff can be huge. Here are the 10 must-do items that all public biotech companies should address in an effective IR program in order to attract the right investors.
Continue Reading
Posted on August 24th, 2021. Posted by ICR Westwicke
Just as schools and businesses run occasional fire drills, your company should periodically pressure test your crisis communications plan. To truly understand if and how the plan will work, your management team and employees need to see how your strategy will play out in a realistic scenario.
Continue Reading
Posted on August 17th, 2021. Posted by ICR Westwicke
Investor conferences offer an effective platform — and a variety of opportunities — for you to tell your story to investors. During the course of the day you may connect with at least a dozen investors and possibly as many as several hundred. What could be better than that?
Continue Reading
Posted on August 10th, 2021. Posted by ICR Westwicke
It’s fair to believe that your business’s strategy and your leadership team’s ability to execute that plan will dictate your fate with investors. More often, however, it’s how those strategies and results are communicated — especially within the investor presentation — that have the most impact on a company’s credibility.
Continue Reading
Posted on August 3rd, 2021. Posted by ICR Westwicke
Whether for a one-on-one at a conference or an IPO road show, your corporate presentation is a critical piece of your investor relations strategy. A PowerPoint deck may seem trivial compared to the entirety of your enterprise, but the investor presentation remains one of the most tangible and effective tools for building (and losing) investor trust and engagement.
Continue Reading
Posted on July 22nd, 2021. Posted by ICR Westwicke
No matter how careful you are as a company, you can quickly find yourself in the center of a crisis you didn’t expect. When that crisis disrupts operations or threatens the reputation of the company, you must act swiftly but carefully.
Continue Reading
Posted on July 8th, 2021. Posted by ICR Westwicke
What is an 8-K?
Form 8-K, also known as an 8K, is a form that is filed by public companies to notify their shareholders and the Securities and Exchange Commission (SEC) when an unscheduled material event takes place. In other words, it’s an announcement that a major event or corporate change that may be of interest to investors, has occurred. Form 8K is known as a “current report” and is filed in addition to an annual report on Form 10-K and a quarterly report on Form 10-Q.
Continue Reading
Posted on June 21st, 2021. Posted by ICR Westwicke
There’s a saying in investor relations: “You date your investment bankers, but you marry your research analysts.” Essentially, this means that a sell side analyst who covers your company will remain your partner for the long run. Investment bankers, on the other hand, work with a long list of companies and deal with jam-packed, demanding schedules. They don’t disappear after the initial public offering (IPO), but the time they can devote to your company diminishes.
Continue Reading
